The Alberta Gaming, Liquor and Cannabis Commission (AGLC) has reversed a controversial policy change that affected the inclusion of cannabinoids CBN (cannabinol) and THCV (tetrahydrocannabivarin) in THC (tetrahydrocannabinol) totals. The agency specifically asked whether limits on delta-9-THC in cannabis products should apply to all intoxicating cannabinoids present in the product. Still, it highlights the urgent need for better communication and cooperation between regulatory bodies and the licensed producers they oversee. These lapses in communication can lead to significant disruptions in the cannabis industry, impacting both businesses and consumers alike. With more explicit guidance and a collaborative approach, Canada’s cannabis industry can continue to mature and thrive, providing consumers with safe, high-quality products and fulfilling the potential of the country’s recreational market.
The Alberta Gaming, Liquor and Cannabis Commission (AGLC) has reversed a controversial policy change that affected the inclusion of cannabinoids CBN (cannabinol) and THCV (tetrahydrocannabivarin) in THC (tetrahydrocannabinol) totals. In a letter sent to licensed cannabis producers on September 18, the AGLC admitted to a misinterpretation of federal messaging and stated that it would relist and accept new products containing these cannabinoids without including CBN and THCV when determining THC levels until it receives clear direction from Health Canada.
Miscommunication...
Read the full article @ Marijuana Index